1. Home
  2. IDE vs MSLE Comparison

IDE vs MSLE Comparison

Compare IDE & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

HOLD

Current Price

$12.10

Market Cap

199.0M

Sector

Finance

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$8.42

Market Cap

186.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IDE
MSLE
Founded
2010
N/A
Country
United States
Canada
Employees
N/A
21
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.0M
186.9M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
IDE
MSLE
Price
$12.10
$8.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 50.2K
28.2K
Earning Date
01-01-0001
N/A
Dividend Yield
★ 8.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.36
$5.44
52 Week High
$14.30
$13.39

Technical Indicators

Market Signals
Indicator
IDE
MSLE
Relative Strength Index (RSI) 23.36 38.89
Support Level N/A $8.11
Resistance Level $13.95 $8.59
Average True Range (ATR) 0.18 0.46
MACD -0.03 -0.10
Stochastic Oscillator 1.32 2.80

Price Performance

Historical Comparison
IDE
MSLE

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: